← Open Payments lookup

MARK MERRELL: Open Payments

NPI 1922342377 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$402 in 22 payments from 15 companies in 2025. Trend: 2023 $396 · 2024 $73 · 2025 $402

Food & beverage: $402
CompanyPaymentsAmount
Novo Nordisk Inc5$91
Lilly USA, LLC2$50
Axsome Therapeutics, Inc.2$38
Insulet Corporation1$28
VERTEX PHARMACEUTICALS INCORPORATED1$25
Astellas Pharma US Inc1$23
Boehringer Ingelheim Pharmaceuticals, Inc.1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$20
E.R. Squibb & Sons, L.L.C.1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19

Products named: MOUNJARO, Rybelsus, Wegovy, Omnipod, JOURNAVX, Veozah, JARDIANCE, Symbravo.

Industry payments across ID — which companies pay providers there.